Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Biocartis amends IPO

    Biocartis Group N.V., Mechelen, Belgium Business: Diagnostic Date announced: 2015-04-15 Type: IPO To be raised: Up to EUR100 million ($105.6 million) Shares: 8.7 million Price: EUR10-EUR11.50 Underwriters: KBC; Kempen…

    Published on 4/20/2015
  • CoLucid amends IPO

    CoLucid Pharmaceuticals Inc., Durham, N.C. Business: Neurology Date announced: 2015-04-10 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriters: Piper Jaffray; Stifel, Nicolaus; William Blair Note: CoLucid …

    Published on 4/20/2015
  • NeuroMetrix Inc amends follow-on

    NeuroMetrix Inc. (NASDAQ:NURO), Waltham, Mass. Business: Neurology Date announced: 2015-04-13 Type: Follow-on To be raised: Up to $30 million Units: 9.9 million Price prior: $2.05 Underwriters: Maxim Group; Dawson James…

    Published on 4/20/2015
  • OpGen amends IPO

    OpGen Inc., Gaithersburg, Md. Business: Diagnostic, Bioinformatics, Pharmacogenetics Date announced: 2015-04-14 Type: IPO To be raised: Up to $37.5 million Shares: 3.8 million Price: $8-$10 Underwriters: Maxim Group; …

    Published on 4/20/2015
  • Viking Therapeutics amends IPO

    Viking Therapeutics Inc., San Diego, Calif. Business: Endocrine/Metabolic, Musculoskeletal, Hematology Date announced: 2015-04-10 Type: IPO To be raised: Up to $22.5 million Shares: 2.5 million Price: $7-$9 Underwriters…

    Published on 4/20/2015
  • Aduro Biotech Inc completes IPO

    Aduro Biotech Inc. (NASDAQ:ADRO), Berkeley, Calif. Business: Cancer Date completed: 2015-04-14 Type: IPO Raised: $119 million Shares: 7 million Price: $17 Shares after offering: 59 million Underwriters: BofA Merrill …

    Published on 4/20/2015
  • Akebia Therapeutics Inc completes follow-on

    Akebia Therapeutics Inc. (NASDAQ:AKBA), Cambridge, Mass. Business: Hematology, Cardiovascular Date completed: 2015-04-16 Type: Follow-on Raised: $60 million Shares: 7.3 million Price: $8.25 Shares after offering: 27.7 …

    Published on 4/20/2015
  • BioAegis Therapeutics completes venture financing

    BioAegis Therapeutics Corp., Morristown, N.J. Business: Inflammation, Infectious Date completed: 2015-04-15 Type: Venture financing Raised: $8 million Investor: Not disclosed Note: The financing is a convertible note.

    Published on 4/20/2015
  • Biodel Inc completes follow-on

    Biodel Inc. (NASDAQ:BIOD), Danbury, Conn. Business: Endocrine/Metabolic, Drug delivery Date completed: 2015-04-15 Type: Follow-on Raised: $30 million Shares: 32.6 million Price: $0.92 Shares after offering: 57.2 million…

    Published on 4/20/2015
  • BoneSupport completes venture financing

    BoneSupport AB, Lund, Sweden Business: Musculoskeletal Date completed: 2015-04-15 Type: Venture financing Raised: $14 million Investor: Existing investors

    Published on 4/20/2015
  • Cidara Therapeutics Inc completes IPO

    Cidara Therapeutics Inc. (NASDAQ:CDTX), San Diego, Calif. Business: Infectious Date completed: 2015-04-15 Type: IPO Raised: $76.8 million Shares: 4.8 million Price: $16 Shares after offering: 13.5 million Underwriters: …

    Published on 4/20/2015
  • Cipher Pharmaceuticals Inc completes private placement of senior notes

    Cipher Pharmaceuticals Inc. (TSX:DND; NASDAQ:CPHR), Mississauga, Ontario Business: Endocrine/Metabolic, Neurology, Dermatology Date completed: 2015-04-13 Type: Private placement of senior notes Raised: $40 million …

    Published on 4/20/2015
  • Clyde Biosciences completes venture financing

    Clyde Biosciences Ltd., Glasgow, U.K. Business: Supply/Service Date completed: 2015-04-13 Type: Venture financing Raised: L2 million ($2.9 million) Investors: Epidarex Capital; Scottish Investment Bank; Glasgow …

    Published on 4/20/2015
  • Concordia Healthcare Corp completes private placement of senior notes

    Concordia Healthcare Corp. (TSX:CXR; OTCQX:CHEHF), Oakville, Ontario Business: Neurology, Inflammation, Cancer Date completed: 2015-04-13 Type: Private placement of senior notes Raised: $735 million Investor: …

    Published on 4/20/2015
  • Esperas Pharma completes venture financing

    Esperas Pharma Inc., Montreal, Quebec Business: Cancer Date completed: 2015-04-13 Type: Venture financing Raised: $16.5 million Investors: TVM Life Science Ventures; Fonds de solidarite FTQ

    Published on 4/20/2015
  • Foamix Pharmaceuticals Ltd completes follow-on

    Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), Rehovot, Israel Business: Autoimmune, Dermatology, Drug delivery Date completed: 2015-04-15 Type: Follow-on Raised: $60 million Shares: 6.5 million Price: $9.30 Shares after …

    Published on 4/20/2015
  • Guided Therapeutics Inc completes private placement of common stock and warrants

    Guided Therapeutics Inc. (OTCBB:GTHP), Norcross, Ga. Business: Diagnostic Date completed: 2015-04-15 Type: Private placement of common stock and warrants Raised: $720,000 Shares: 4 million Price: $0.18 Shares after …

    Published on 4/20/2015
  • Horizon Pharma pl completes follow-on

    Horizon Pharma plc (NASDAQ:HZNP), Dublin, Ireland Business: Autoimmune, Inflammation, Neurology Date completed: 2015-04-15 Type: Follow-on Raised: $433.6 million Shares: 15.4 million Price: $28.25 Shares after offering:…

    Published on 4/20/2015
  • Ignyta Inc completes direct public offering

    Ignyta Inc. (NASDAQ:RXDX), San Diego, Calif. Business: Cancer, Diagnostic Date completed: 2015-03-17 Type: Direct public offering Raised: $41.6 million Shares: 4.2 million Price: $10 Shares after offering: 23.7 million …

    Published on 4/20/2015
  • Immune Design Corp completes follow-on

    Immune Design Corp. (NASDAQ:IMDZ), Seattle, Wash. Business: Infectious, Cancer Date completed: 2015-04-15 Type: Follow-on Raised: $79.5 million Shares: 3 million Price: $26.50 Shares after offering: 20 million …

    Published on 4/20/2015
  • Innocrin Pharmaceuticals completes venture financing

    Innocrin Pharmaceuticals Inc., Durham, N.C. Business: Cancer Date completed: 2015-04-14 Type: Venture financing Raised: $28 million Investors: Eshelman Ventures; Novartis Venture Funds; Lilly Ventures; Hatteras Venture …

    Published on 4/20/2015
  • KemPharm Inc completes IPO

    KemPharm Inc. (NASDAQ:KMPH), Coralville, Iowa Business: Neurology Date completed: 2015-04-16 Type: IPO Raised: $56 million Shares: 5.1 million Price: $11 Shares after offering: 13.5 million Underwriters: Cowen; RBC …

    Published on 4/20/2015
  • Matinas BioPharma Holdings Inc completes private placement of units

    Matinas BioPharma Holdings Inc. (OTCQB:MTNB), Bedminster, N.J. Business: Cardiovascular Date completed: 2015-04-10 Type: Private placement of units Raised: $5.1 million Units: 10.1 million Price: $0.50 (unit) Shares …

    Published on 4/20/2015
  • Merus Labs International Inc completes follow-on

    Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Date completed: 2015-04-13 Type: Follow-on Raised: C$60 million ($47.5 million) Shares: 19.7 million Price: C$3.05…

    Published on 4/20/2015
  • Miraculins Inc completes private placement of units

    Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date completed: 2015-04-10 Type: Private placement of units Raised: C$250,000 ($197,925) Units: 2.5 million Price: C$0.10 (unit) Shares …

    Published on 4/20/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993